La enfermedad de Alzheimer: ¿Modelo de alfa-sinucleopatÃa?
Resumen
Carta el editor sobre el artÃculo:
Disbiosis intestinal en la enfermedad de Alzheimer
Referencias
DÃaz GEF, Cabodevilla RCV. Disbiosis intestinal en la enfermedad de Alzheimer. Correo CientÃfico Médico 2023 [citado 11/05/2023];27(1). Disponible en:
https://revcocmed.sld.cu/index.php/cocmed/article/view/4680
Shim KH, Kang MJ, Youn YC, An SSA, Kim S. Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease. Alzheimers Res Ther. 2022 [citado 20/05/2023];14(1):201. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/36587215
Ciaccioli G, Martins A, Rodrigues C, Vieira H, Calado P. A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration. PLoS One. 2013 [citado 12/05/2023];8(2):e55848. Disponible en:
https://www.ncbi.nlm.nih.gov/pubmed/23339603
Twohig D, Nielsen HM. α-synuclein in the pathophysiology of Alzheimer’s disease. Mol Neurodegener. 2019 [citado23/05/2023];14(1):23. Disponible en:
https://www.ncbi.nlm.nih.gov/pubmed/31186026
Brás IC, Outeiro TF. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells. 2021 [citado 15/04/2023];10(2):375. Disponible en:
https://www.ncbi.nlm.nih.gov/pubmed/33673034
Murros KE, Huynh VA, Takala TM, Saris PEJ. Desulfovibrio Bacteria Are Associated With Parkinson’s Disease. Front Cell Infect Microbiol. 2021 [citado 14/05/2023];11:652617. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/34012926
Copyright (c) 2023 Amilkar Suárez, Sonia Navarro Arrieta, Miguel Antonio Delgado Fernández
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.